Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
lysophosphatidylcholine acyltransferase 3 | 0.736 | 0.346 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1978 | 1978 | ||||||||
|
chromodomain helicase DNA binding protein 1 like | 0.631 | 0.577 | 1.0E-36 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1978 | 1978 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.200 | None | 0.938 | 15 | 0 | 1980 | 2019 | |||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.700 | None | 0.966 | 175 | 7 | 1983 | 2019 | ||||||||
|
G protein-coupled receptor 162 | 0.631 | 0.654 | 9.4E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1984 | 2002 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.500 | None | 0.960 | 95 | 4 | 1986 | 2019 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
disease | 0.500 | None | 0.967 | 86 | 11 | 1986 | 2020 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
disease | 0.100 | None | 0.914 | 56 | 2 | 1986 | 2018 | ||||||||
|
junctophilin 3 | 0.608 | 0.538 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1987 | 2017 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
disease | 0.500 | None | 0.968 | 148 | 3 | 1988 | 2019 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
disease | 0.070 | None | 0.857 | 7 | 2 | 1988 | 2020 | ||||||||
|
apolipoprotein C3 | 0.531 | 0.731 | 1.0E-02 |
|
disease | 0.100 | None | 1.000 | 39 | 3 | 1989 | 2019 | ||||||||
|
cholesteryl ester transfer protein | 0.512 | 0.731 | 1.2E-23 |
|
disease | 0.200 | None | 0.947 | 91 | 6 | 1990 | 2020 | ||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
disease | 0.060 | None | 0.667 | 6 | 0 | 1990 | 2018 | |||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.500 | None | 0.912 | 110 | 8 | 1991 | 2019 | ||||||||
|
lipoprotein(a) like 2, pseudogene | 0.626 | 0.731 |
|
disease | 0.160 | None | 1.000 | 6 | 0 | 1991 | 2017 | |||||||||
|
apolipoprotein A2 | 0.582 | 0.769 | 4.5E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 1991 | 2017 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.400 | None | 0.920 | 174 | 4 | 1992 | 2020 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.100 | None | 0.907 | 41 | 2 | 1992 | 2019 | ||||||||
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 0.482 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 34 | 3 | 1992 | 2019 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.310 | None | 1.000 | 1 | 1 | 1992 | 2014 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.400 | None | 0.987 | 75 | 6 | 1993 | 2020 | ||||||||
|
haptoglobin | 0.412 | 0.885 | 1.7E-05 |
|
disease | 0.100 | None | 0.950 | 20 | 0 | 1993 | 2020 | ||||||||
|
ataxin 2 like | 0.695 | 0.423 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1993 | 1993 | ||||||||
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | 0.546 | 0.846 | 4.0E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 |